"We judge that some elements of Syria's biological warfare program might have advanced beyond the research and development stage and might be capable of limited agent production, based on the duration of its longstanding program," James Clapper, director of national intelligence, said in a written statement presented to the Senate Intelligence Committee.
Clapper offered no further details but it was the first time officials had stated publicly that America's spy agencies believed Syria had made significant strides in its biological weapons program.
"To the best of our knowledge, Syria has not successfully weaponized biological agents in an effective delivery system, but it possesses conventional weapon systems that could be modified for biological-agent delivery," he said.
Clapper also said the civil war in Syria had become a "huge magnet" for Islamist extremists, including Al-Qaeda-linked groups.
The UN Security Council last year approved a US-Russian deal to remove and destroy Syria's chemical arsenal.
The agreement was brokered as a way to avert US missile strikes that Washington threatened after a chemical attack near Damascus, which Washington and other Western governments blamed on the regime.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
